Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Sabina Frljak"'
Publikováno v:
Cell Transplantation, Vol 31 (2022)
We investigated the effects of cell therapy on local mechanical dyssynchrony (LMD) in patients with nonischemic dilated cardiomyopathy (NICM). We analyzed electromechanical data of 30 NICM patients undergoing CD34 + cell transplantation. All patients
Externí odkaz:
https://doaj.org/article/5062b8ab3eb746dab7a3273fb820ebb6
Publikováno v:
Cardiac Failure Review, Vol 8, Iss , Pp - (2022)
Heart failure with preserved ejection fraction (HFpEF) is the most common cause of hospitalisation for heart failure. However, only limited effective treatments are available. Recent evidence suggests that HFpEF may result from a systemic proinflamma
Externí odkaz:
https://doaj.org/article/a83febc5bc3247afb6be928e973ff9d7
Autor:
Andraz Cerar, Martina Jaklic, Sabina Frljak, Gregor Poglajen, Gregor Zemljic, Barbara Guzic Salobir, Maja Dolenc Novak, Monika Stalc, Rok Zbacnik, Mirta Kozelj
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 1161-1167 (2020)
ABSTRACT Aims Non‐compaction cardiomyopathy (NCM) is a congenital heart disease characterized by an arrest of the myocardial compaction process. Although NCM patients have impaired formation of microvasculature, the functional impact of these chang
Externí odkaz:
https://doaj.org/article/3f0eea0cc3bd4b788e0955c7f1dbb76e
Autor:
Andraz Cerar, Martina Jaklic, Sabina Frljak, Gregor Poglajen, Gregor Zemljic, Barbara Guzic Salobir, Maja Dolenc Novak, Monika Stalc, Rok Zbacnik, Mirta Kozelj
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1999-2000 (2020)
Externí odkaz:
https://doaj.org/article/f19fc05b39d64b4fb2c5a121bae365bb
Autor:
Gregor Poglajen, Gregor Zemljič, Andraž Cerar, Sabina Frljak, Martina Jaklič, Vesna Androcec, Bojan Vrtovec
Publikováno v:
Cell Transplantation, Vol 28 (2019)
Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34 + cell therapy on VA burden in patients with chronic heart failure (CHF). We pe
Externí odkaz:
https://doaj.org/article/9bb27e21679c4455b6d90136cd459a56
Autor:
Cecilie Hoeeg, Sabina Frljak, Abbas Ali Qayyum, Bojan Vrtovec, Jens Kastrup, Annette Ekblond, Bjarke Follin
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 570 (2020)
Non-ischemic dilated cardiomyopathy (NIDCM) constitutes one of the most common causes to non-ischemic heart failure. Despite treatment, the disease often progresses, causing severe morbidity and mortality, making novel treatment strategies necessary.
Externí odkaz:
https://doaj.org/article/96cdde290bd04eceb9edfe65824f12ce
Autor:
Gregor Poglajen, Ajda Anžič-Drofenik, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Renata Okrajšek, Miran Šebeštjen, Bojan Vrtovec
Publikováno v:
Diagnostics, Vol 10, Iss 8, p 522 (2020)
Background. We sought to evaluate the long-term effects of angiotensin receptor blocker–neprilysin inhibitor (ARNI) therapy on reverse remodeling of the failing myocardium in HFrEF patients. Methods. We performed a prospective non-randomized longit
Externí odkaz:
https://doaj.org/article/a64a097ff8ab44269f66379fb6f65be2
Autor:
Andraz Cerar, Gregor Zemljic, Sabina Frljak, Martina Jaklic, Gregor Poglajen, Matjaz Sever, Marko Cukjati, Bojan Vrtovec
Publikováno v:
Cell Transplantation, Vol 27 (2018)
Noncompaction cardiomyopathy is a rare congenital heart disorder characterized by an arrest of the myocardial compaction process. This results in the altered formation of coronary microvessels with a resulting decrease in myocardial perfusion. Transe
Externí odkaz:
https://doaj.org/article/a68dd20d129143e1b4834c9449e036d1
Autor:
Gregor Poglajen, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Vesna Andročec, Matjaž Sever, Peter Černelč
Publikováno v:
Stem Cells International, Vol 2018 (2018)
Aim of the Review. The aim of this review is to discuss recent advances in clinical aspects of stem cell therapy in chronic nonischemic heart failure (DCMP) with emphasis on patient selection, stem cell types, and delivery methods. Recent Findings. S
Externí odkaz:
https://doaj.org/article/c8f87b658adf4c2787e23d050682982f
Autor:
Bojan Vrtovec, Sabina Frljak, Gregor Poglajen, Gregor Zemljic, Andraz Cerar, Matjaz Sever, Francois Haddad, Joseph C. Wu
Publikováno v:
European journal of heart failure. 24(8)
We investigated the effects of CD34In a prospective pilot study, we enrolled 30 patients with HFpEF. In Phase 1, patients were treated with medical therapy for 6 months. Thereafter, all patients underwent CD34In this non-randomized trial, transendoca